<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Saclay_Notebook_August_17 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Saclay/Notebook/August/17</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container-fluid nav-container"><NAV class="navbar navbar-default navbar-inverse affix-top" data-spy="affix" data-offset-top="260"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav center-block"><LI><A href="https://2016.igem.org/Team:Paris_Saclay">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Media">Media</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Sponsors">Sponsors</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Acknowledgements">Acknowledgements</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Background">Background</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Design">Design</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Experiments">Experiments</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Perspective">Perspective</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Interlab_Study">Interlab Study</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Basic_Part">Basic Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Pratices </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Silver">Societal Issues of CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Gold">Responsible Research and Innovation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices/GMO_Regulation">GMO regulation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Engagement">Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Safety">Safety</A></LI></DIV></DIV></NAV></DIV><DIV class="container content"><DIV id="main"><DIV id="toc" class="toc"><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Wednesday_17th_August"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Wednesday 17<SUP>th</SUP> August</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Biobrick_characterisation"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Biobrick characterisation</SPAN></A></LI><LI class="toclevel-3 tocsection-3"><A href="#Culture_of_BL21.7CK1372001_and_pcl_TAA.2C_pclTAG_or_pclTq"><SPAN class="tocnumber">1.1.1</SPAN><SPAN class="toctext">Culture of BL21|K1372001 and pcl_TAA, pclTAG or pclTq</SPAN></A></LI></UL><LI class="toclevel-2 tocsection-4"><A href="#Visualization"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">Visualization</SPAN></A></LI><LI class="toclevel-3 tocsection-5"><A href="#Extraction_of_pPS16_003.2C_pPS16_004_and_GFP1-9_PSB1C3_.28clones_2_and_3.29"><SPAN class="tocnumber">1.2.1</SPAN><SPAN class="toctext">Extraction of pPS16_003, pPS16_004 and GFP1-9_PSB1C3 (clones 2 and 3)</SPAN></A></LI><LI class="toclevel-3 tocsection-6"><A href="#Purification_of_gBlocks_2.2C_3_and_4"><SPAN class="tocnumber">1.2.2</SPAN><SPAN class="toctext">Purification of gBlocks 2, 3 and 4</SPAN></A></LI><LI class="toclevel-3 tocsection-7"><A href="#Cloning_with_pJET_the_gBlock_1.2.2C_FRB.2C_FKBP_and_SgNM"><SPAN class="tocnumber">1.2.3</SPAN><SPAN class="toctext">Cloning with pJET the gBlock 1.2, FRB, FKBP and SgNM</SPAN></A></LI><LI class="toclevel-3 tocsection-8"><A href="#Q5_PCR_on_gBlocks_.281.2.2C_NM_Sg_RNA.2C_FRB_and_FKBP.29_and_products_of_4.1_and_4.2_gBlocks_ligation"><SPAN class="tocnumber">1.2.4</SPAN><SPAN class="toctext">Q5 PCR on gBlocks (1.2, NM_Sg_RNA, FRB and FKBP) and products of 4.1 and 4.2 gBlocks ligation</SPAN></A></LI><LI class="toclevel-3 tocsection-9"><A href="#Total_volume_migration_of_PCR_products_1.2_and_Lig_4"><SPAN class="tocnumber">1.2.5</SPAN><SPAN class="toctext">Total volume migration of PCR products 1.2 and Lig 4</SPAN></A></LI><LI class="toclevel-3 tocsection-10"><A href="#Low_Fidelity_DreamTaqPCR_of_DH5a.7CpPS16_020.2C_DH5a.7CpPS16_010.2C_DH5a.7CpPS16_012_and_DH5a.7CpPS16_013"><SPAN class="tocnumber">1.2.6</SPAN><SPAN class="toctext">Low Fidelity DreamTaqPCR of DH5a|pPS16_020, DH5a|pPS16_010, DH5a|pPS16_012 and DH5a|pPS16_013</SPAN></A></LI><LI class="toclevel-3 tocsection-11"><A href="#Digestion_of_pPS16_013_clones_2_and_3"><SPAN class="tocnumber">1.2.7</SPAN><SPAN class="toctext">Digestion of pPS16_013 clones 2 and 3</SPAN></A></LI></DIV><H1><SPAN class="mw-headline" id="Wednesday_17th_August">Wednesday 17<SUP>th</SUP> August</SPAN></H1><H3><SPAN class="mw-headline" id="Biobrick_characterisation">Biobrick characterisation</SPAN></H3><H4><SPAN class="mw-headline" id="Culture_of_BL21.7CK1372001_and_pcl_TAA.2C_pclTAG_or_pclTq">Culture of BL21|K1372001 and pcl_TAA, pclTAG or pclTq</SPAN></H4><P><I>By Charlène</I></P><P>3 clones from each transformation condition (K1372001 and pcl_TAA, pclTAG or pclTq) were grown in 500µL of LB, streptomycin (50µg/mL) and chloramphenicol (30µg/mL).
Then each solution was split into 3x150µL and 350µL of mix of LB + streptomycin (50µg/mL) + chloramphenicol (30µg/mL) were added to each culture.
Salicylate (main solution at 10mM) was added to obtain the following concentrations : 0, 0.03mM and 1mM.
</P><H3><SPAN class="mw-headline" id="Visualization">Visualization</SPAN></H3><H4><SPAN class="mw-headline" id="Extraction_of_pPS16_003.2C_pPS16_004_and_GFP1-9_PSB1C3_.28clones_2_and_3.29">Extraction of pPS16_003, pPS16_004 and GFP1-9_PSB1C3 (clones 2 and 3)</SPAN></H4><P><I>By Charlène</I></P><P>Clones 2 and 3 of GFP1-9_PSB1C3, and pPS16_003, pPS16_004 were extracted with the <A href="/Team:Paris_Saclay/Experiments#InvitrogenPlasmidExtraction" title="Team:Paris Saclay/Experiments">Plasmid MiniPrep kit</A>.
</P><P>The extracts were put on migration on a 0.8%agarose gel with BET.
</P><H4><SPAN class="mw-headline" id="Purification_of_gBlocks_2.2C_3_and_4">Purification of gBlocks 2, 3 and 4</SPAN></H4><P><I>By Terrence</I></P><P>The purification was carried out following the usual <A href="/Team:Paris_Saclay/Experiments#DNA_extraction_from_agarose_gels_with_NucleoSpin_Gel_and_PCR_Clean-up" title="Team:Paris Saclay/Experiments">protocol</A>.
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Result of the extraction of pPS16003, pPS16004 and GFP1-9_PSB1C3 (clones 2 and 3) and result of the migration of gBlock 2-3-4</DIV></DIV></DIV><H4><SPAN class="mw-headline" id="Cloning_with_pJET_the_gBlock_1.2.2C_FRB.2C_FKBP_and_SgNM">Cloning with pJET the gBlock 1.2, FRB, FKBP and SgNM</SPAN></H4><P><I>By Léa and Naiane</I></P><P>The cloning was carried out using a new <A href="/Team:Paris_Saclay/Experiments#ligation_with_pJet" title="Team:Paris Saclay/Experiments">protocol</A> which uses pJET as cloning vector.
</P><P>A heat shock transformation was made on the cloning samples using the following <A href="/Team:Paris_Saclay/Experiments#heat-shocktransformation" title="Team:Paris Saclay/Experiments">protocol</A></P><H4><SPAN class="mw-headline" id="Q5_PCR_on_gBlocks_.281.2.2C_NM_Sg_RNA.2C_FRB_and_FKBP.29_and_products_of_4.1_and_4.2_gBlocks_ligation">Q5 PCR on gBlocks (1.2, NM_Sg_RNA, FRB and FKBP) and products of 4.1 and 4.2 gBlocks ligation</SPAN></H4><P><I>By Alice</I></P><P>Q5 PCR was performed directly on gBlocks to amplify them following <A href="/Team:Paris_Saclay/Experiments#Q5PCR" title="Team:Paris Saclay/Experiments">this protocol</A>.
<A href="/Team:Paris_Saclay/Experiments#primers" title="Team:Paris Saclay/Experiments">Primers</A> used were:
</P><TABLE class="wikitable"><TBODY><TR><TH>gBlocks
</TH><TH>1.2
</TH><TH>NM_Sg_RNA
</TH><TH>FRB
</TH><TH>FKBP
</TH><TH>4.1 and 4.2 gBlocks ligation
</TH></TR><TR><TD>Primers
</TD><TD>iPS121 and iPS122
</TD><TD>iPS133 and iPS83
</TD><TD>iPS149 and iPS150
</TD><TD>iPS145 and iPS146
</TD><TD>iPS129 and iPS84
</TD></TR></TBODY></TABLE><P>Annealing temperature was 70°C. After amplification, 1 µL of each PCR products and 10 µL of DNA ladder were placed on gel and migrated at 100v during 30 min.
</P><P>PCR products expected were :
</P><TABLE class="wikitable"><TBODY><TR><TH>gBlocks
</TH><TH>expected band size (bp)
</TH></TR><TR><TD>1.2
</TD><TD>960
</TD></TR><TR><TD>NM_Sg_RNA
</TD><TD>362
</TD></TR><TR><TD>FRB
</TD><TD>473
</TD></TR><TR><TD>FKBP
</TD><TD>419
</TD></TR><TR><TD>4.1 and 4.2 gBlocks ligation
</TD><TD>1994
</TD></TR></TBODY></TABLE><DIV class="thumb tright"><DIV class="thumbinner" style="width:481px;"><DIV class="thumbcaption">Migration of gBlocks and ligation</DIV></DIV></DIV><H4><SPAN class="mw-headline" id="Total_volume_migration_of_PCR_products_1.2_and_Lig_4">Total volume migration of PCR products 1.2 and Lig 4</SPAN></H4><P><I>By Terrence</I></P><P>A second migration on agarose gel was performed with the total volume of the PCR products 1.2 and 4.
The migration allowed us to excise the DNA fragments from the agarose gel below and carried on with the Step 1 of the NucleoSpin Gel and PCR Clean-up kit <A href="/Team:Paris_Saclay/Experiments#Purification" title="Team:Paris Saclay/Experiments">protocol</A>.
</P><P>The excised bands from Step 1 were incubated with the buffer NT1 at 4°C overnight.
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Gel extraction fo 1.2 and Lig 4</DIV></DIV></DIV><H4><SPAN class="mw-headline" id="Low_Fidelity_DreamTaqPCR_of_DH5a.7CpPS16_020.2C_DH5a.7CpPS16_010.2C_DH5a.7CpPS16_012_and_DH5a.7CpPS16_013">Low Fidelity DreamTaqPCR of DH5a|pPS16_020, DH5a|pPS16_010, DH5a|pPS16_012 and DH5a|pPS16_013</SPAN></H4><P><I>By Mathilde</I></P><P>PCR was performed on clones 1 to 5 for pPS16_020, clones 1,2,3,5 and 6 for pPS16_010, clones 1,2,3 and 6 for pPS16_012, and for clones 1,4 and 6 for pPS16_013. Both white and blue colonies were picked for each plasmids.
</P><P>Thus, the PCR mix was done for 17 tubes following the usual <A href="/Team:Paris_Saclay/Experiments#Polymerase_chain_reaction" title="Team:Paris Saclay/Experiments">protocol</A>. But 1µL of dNTPs were used instead of 2,5µL, and colonies were put in the water before the addition of the rest of the mix for each sample.
Primers 1151 and 1152 were used, the initial denaturation time was 5min, and Tm = 57°c.
</P><P>Each clone was put in liquide culture (LB 3mL + Ampicillin 50µg/mL)
</P><P>Each PCR product was placed on agarose gel to migrate.
10µL of violet ladder was used.
</P><P>PCR products expected were :
</P><TABLE class="wikitable"><TBODY><TR><TH><B>Plasmid</B></TH><TH>pPS16_020
</TH><TH>pPS16_010
</TH><TH>pPS16_012
</TH><TH>pPS16_013
</TH></TR><TR><TH><B>Band Size (bp)</B></TH><TD>862
</TD><TD>374
</TD><TD>419
</TD><TD>362
</TD></TR></TBODY></TABLE><DIV class="thumb tright"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Result of the PCR</DIV></DIV></DIV><P>No PCR product presented the expected size.
</P><H4><SPAN class="mw-headline" id="Digestion_of_pPS16_013_clones_2_and_3">Digestion of pPS16_013 clones 2 and 3</SPAN></H4><P><I>By Mathilde</I></P><P>The two plasmids were digested with the XbaI and PstI enzymes with the following protocol :
</P><UL><LI> 2µL of plasmid</LI><LI> 0,5µL of each restriction enzyme</LI><LI> 1µL of Green Fast Digestion Buffer</LI><LI> 6 µL of sterile water</LI></UL><P>The two preparations were put for incubation during 5 min at 37°c, and then directly put to migrate.
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Result of the migration</DIV></DIV></DIV></DIV></DIV><DIV class=" footer"><DIV class="container"><DIV class="adress"><ADRESS>Université Paris Sud
91405 Orsay, France</ADRESS></DIV><SMALL class="envers copyright">Copyright © 2016 iGEM Paris Saclay. <STRIKE>All rights reserved</STRIKE> All inspirations encouraged.*This wiki was conceived during long nights of work and a great coffee experience in the beautiful Orsay, France.</SMALL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>